Neftali Eduardo Antonio-Villa, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Mexico | 21 | 2024 | 723 | 1.790 |
Why?
|
Myocardial Perfusion Imaging | 4 | 2022 | 552 | 1.300 |
Why?
|
Insulin Resistance | 6 | 2023 | 3889 | 0.910 |
Why?
|
Intra-Abdominal Fat | 4 | 2023 | 600 | 0.820 |
Why?
|
Ventricular Dysfunction, Left | 4 | 2023 | 2088 | 0.660 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 3 | 2022 | 1101 | 0.650 |
Why?
|
Nutrition Surveys | 4 | 2022 | 1684 | 0.590 |
Why?
|
Diabetes Mellitus, Type 2 | 10 | 2023 | 11909 | 0.590 |
Why?
|
Adiposity | 3 | 2023 | 1823 | 0.510 |
Why?
|
Myocardial Ischemia | 3 | 2023 | 2152 | 0.510 |
Why?
|
Coronary Artery Disease | 4 | 2023 | 6565 | 0.500 |
Why?
|
Vascular Diseases | 1 | 2022 | 1160 | 0.470 |
Why?
|
Hypertension | 5 | 2024 | 8614 | 0.370 |
Why?
|
Diabetes Mellitus, Type 1 | 2 | 2021 | 3374 | 0.350 |
Why?
|
Comorbidity | 7 | 2023 | 10450 | 0.350 |
Why?
|
Diabetes Mellitus | 3 | 2022 | 5799 | 0.330 |
Why?
|
Perfusion | 2 | 2022 | 1364 | 0.280 |
Why?
|
Blood Glucose | 6 | 2021 | 6318 | 0.260 |
Why?
|
Cross-Sectional Studies | 11 | 2024 | 25454 | 0.230 |
Why?
|
Ebstein Anomaly | 1 | 2023 | 99 | 0.210 |
Why?
|
Death Certificates | 1 | 2022 | 172 | 0.200 |
Why?
|
Hyperlipidemia, Familial Combined | 1 | 2021 | 11 | 0.200 |
Why?
|
Cholesterol, VLDL | 1 | 2021 | 65 | 0.190 |
Why?
|
Blood Glucose Self-Monitoring | 2 | 2021 | 454 | 0.190 |
Why?
|
Guillain-Barre Syndrome | 1 | 2022 | 122 | 0.190 |
Why?
|
Bullying | 1 | 2023 | 210 | 0.190 |
Why?
|
Pulmonary Edema | 1 | 2024 | 417 | 0.190 |
Why?
|
Cardiac-Gated Single-Photon Emission Computer-Assisted Tomography | 1 | 2019 | 4 | 0.180 |
Why?
|
Humans | 47 | 2024 | 752741 | 0.170 |
Why?
|
Cities | 1 | 2022 | 518 | 0.170 |
Why?
|
Electronics | 1 | 2020 | 324 | 0.160 |
Why?
|
Adipose Tissue | 4 | 2023 | 3308 | 0.160 |
Why?
|
Cause of Death | 3 | 2023 | 3628 | 0.160 |
Why?
|
Antigens, Viral | 1 | 2021 | 1035 | 0.150 |
Why?
|
Hepatitis B | 1 | 2022 | 702 | 0.150 |
Why?
|
Middle Aged | 20 | 2024 | 216054 | 0.140 |
Why?
|
Severity of Illness Index | 4 | 2022 | 15657 | 0.140 |
Why?
|
Male | 24 | 2024 | 354311 | 0.140 |
Why?
|
Adult | 20 | 2023 | 216658 | 0.130 |
Why?
|
RNA, Viral | 2 | 2021 | 2908 | 0.130 |
Why?
|
Female | 25 | 2024 | 385090 | 0.130 |
Why?
|
Uric Acid | 1 | 2022 | 776 | 0.130 |
Why?
|
Hyperlipoproteinemia Type II | 1 | 2020 | 381 | 0.130 |
Why?
|
Prevalence | 3 | 2022 | 15404 | 0.130 |
Why?
|
Prediabetic State | 1 | 2021 | 510 | 0.130 |
Why?
|
Pandemics | 4 | 2022 | 8607 | 0.130 |
Why?
|
Cholesterol, LDL | 2 | 2022 | 2385 | 0.130 |
Why?
|
Age of Onset | 1 | 2022 | 3290 | 0.130 |
Why?
|
Goals | 1 | 2020 | 716 | 0.120 |
Why?
|
Mortality | 2 | 2022 | 2899 | 0.120 |
Why?
|
Cardiovascular System | 1 | 2021 | 834 | 0.110 |
Why?
|
Cardiac Resynchronization Therapy | 1 | 2019 | 535 | 0.110 |
Why?
|
Ventricular Remodeling | 1 | 2021 | 1229 | 0.110 |
Why?
|
Body Composition | 1 | 2022 | 2439 | 0.110 |
Why?
|
Prospective Studies | 6 | 2023 | 53863 | 0.110 |
Why?
|
Obesity | 4 | 2023 | 12868 | 0.110 |
Why?
|
Metabolic Diseases | 1 | 2019 | 671 | 0.110 |
Why?
|
Pneumonia, Viral | 2 | 2021 | 3246 | 0.110 |
Why?
|
Hepatitis C | 1 | 2022 | 1597 | 0.100 |
Why?
|
Renal Insufficiency, Chronic | 2 | 2024 | 2191 | 0.100 |
Why?
|
Risk Factors | 8 | 2023 | 73094 | 0.100 |
Why?
|
Reference Values | 1 | 2019 | 4994 | 0.100 |
Why?
|
Retrospective Studies | 8 | 2023 | 78758 | 0.100 |
Why?
|
Cardiovascular Diseases | 4 | 2021 | 15433 | 0.100 |
Why?
|
Cardiomyopathies | 1 | 2023 | 1895 | 0.100 |
Why?
|
Motivation | 1 | 2020 | 1990 | 0.090 |
Why?
|
Incidence | 4 | 2022 | 21146 | 0.090 |
Why?
|
Aged | 9 | 2022 | 165629 | 0.090 |
Why?
|
Regression Analysis | 1 | 2019 | 6458 | 0.080 |
Why?
|
Health Status Disparities | 1 | 2021 | 1812 | 0.080 |
Why?
|
Insulin | 2 | 2021 | 6623 | 0.080 |
Why?
|
Health Personnel | 1 | 2021 | 3246 | 0.080 |
Why?
|
Area Under Curve | 2 | 2021 | 1654 | 0.070 |
Why?
|
Aging | 2 | 2022 | 8752 | 0.070 |
Why?
|
Body Mass Index | 5 | 2022 | 12821 | 0.070 |
Why?
|
Registries | 4 | 2022 | 8216 | 0.070 |
Why?
|
Quality of Health Care | 1 | 2020 | 4385 | 0.060 |
Why?
|
Risk Assessment | 3 | 2020 | 23554 | 0.060 |
Why?
|
Dementia | 1 | 2019 | 2590 | 0.060 |
Why?
|
Triglycerides | 2 | 2022 | 2465 | 0.060 |
Why?
|
Fasting | 2 | 2021 | 1607 | 0.060 |
Why?
|
Disease Susceptibility | 2 | 2021 | 1779 | 0.060 |
Why?
|
Internship and Residency | 1 | 2023 | 5858 | 0.060 |
Why?
|
Delivery of Health Care | 1 | 2021 | 5380 | 0.060 |
Why?
|
ROC Curve | 2 | 2021 | 3558 | 0.060 |
Why?
|
Alzheimer Disease | 2 | 2021 | 8199 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3136 | 0.050 |
Why?
|
Blood Pressure | 3 | 2024 | 8635 | 0.050 |
Why?
|
Hospitalization | 4 | 2023 | 10422 | 0.050 |
Why?
|
Glucose Clamp Technique | 1 | 2022 | 267 | 0.050 |
Why?
|
Renal Replacement Therapy | 1 | 2022 | 245 | 0.050 |
Why?
|
Asymptomatic Infections | 1 | 2021 | 130 | 0.050 |
Why?
|
Vaccination | 2 | 2023 | 3354 | 0.050 |
Why?
|
Heart Failure | 1 | 2024 | 11096 | 0.040 |
Why?
|
Heart Ventricles | 2 | 2023 | 3845 | 0.040 |
Why?
|
Respiratory Rate | 1 | 2020 | 168 | 0.040 |
Why?
|
Apolipoproteins B | 1 | 2021 | 383 | 0.040 |
Why?
|
Ventricular Function, Left | 2 | 2023 | 3715 | 0.040 |
Why?
|
Gadolinium | 1 | 2023 | 959 | 0.040 |
Why?
|
Adaptive Immunity | 1 | 2023 | 727 | 0.040 |
Why?
|
Anthropometry | 1 | 2022 | 1357 | 0.040 |
Why?
|
Immunoglobulins, Intravenous | 1 | 2022 | 658 | 0.040 |
Why?
|
Young Adult | 5 | 2022 | 57267 | 0.040 |
Why?
|
Myocardial Infarction | 1 | 2019 | 11824 | 0.040 |
Why?
|
Pericardium | 1 | 2022 | 672 | 0.040 |
Why?
|
Quality of Life | 3 | 2024 | 13044 | 0.040 |
Why?
|
Stroke Volume | 2 | 2021 | 5103 | 0.040 |
Why?
|
Adipokines | 1 | 2019 | 324 | 0.040 |
Why?
|
Diastole | 1 | 2019 | 792 | 0.040 |
Why?
|
Magnetic Resonance Imaging, Cine | 1 | 2023 | 977 | 0.030 |
Why?
|
HIV Infections | 1 | 2022 | 16882 | 0.030 |
Why?
|
Proportional Hazards Models | 2 | 2021 | 12423 | 0.030 |
Why?
|
Fibrosis | 1 | 2023 | 2028 | 0.030 |
Why?
|
Educational Status | 1 | 2023 | 2573 | 0.030 |
Why?
|
Hypertrophy, Left Ventricular | 1 | 2021 | 854 | 0.030 |
Why?
|
Hepacivirus | 1 | 2022 | 1381 | 0.030 |
Why?
|
HIV | 1 | 2022 | 1610 | 0.030 |
Why?
|
Immunocompromised Host | 1 | 2020 | 847 | 0.030 |
Why?
|
Heart Atria | 1 | 2021 | 1356 | 0.030 |
Why?
|
Docosahexaenoic Acids | 1 | 2021 | 888 | 0.030 |
Why?
|
Ischemia | 1 | 2023 | 1924 | 0.030 |
Why?
|
United States | 1 | 2022 | 70772 | 0.030 |
Why?
|
Triage | 1 | 2020 | 985 | 0.030 |
Why?
|
Age Factors | 2 | 2021 | 18460 | 0.030 |
Why?
|
Renal Dialysis | 1 | 2022 | 1749 | 0.030 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2023 | 3753 | 0.030 |
Why?
|
Nutritional Status | 1 | 2021 | 1610 | 0.030 |
Why?
|
Neoplasms | 1 | 2021 | 21976 | 0.030 |
Why?
|
Cholesterol | 1 | 2021 | 2926 | 0.030 |
Why?
|
Dyslipidemias | 1 | 2019 | 865 | 0.030 |
Why?
|
Prognosis | 2 | 2024 | 29264 | 0.020 |
Why?
|
Life Style | 1 | 2022 | 3861 | 0.020 |
Why?
|
Ultrasonography | 1 | 2024 | 6037 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2020 | 6542 | 0.020 |
Why?
|
Contrast Media | 1 | 2023 | 5338 | 0.020 |
Why?
|
Mental Health | 1 | 2023 | 3074 | 0.020 |
Why?
|
tau Proteins | 1 | 2019 | 1939 | 0.020 |
Why?
|
Hypoglycemic Agents | 1 | 2021 | 2975 | 0.020 |
Why?
|
RNA, Messenger | 1 | 2023 | 13011 | 0.020 |
Why?
|
Cohort Studies | 2 | 2021 | 40939 | 0.020 |
Why?
|
Intensive Care Units | 1 | 2020 | 3717 | 0.020 |
Why?
|
Hospital Mortality | 1 | 2020 | 5367 | 0.020 |
Why?
|
Sex Factors | 1 | 2020 | 10469 | 0.020 |
Why?
|
Sensitivity and Specificity | 1 | 2021 | 14761 | 0.020 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 1 | 2020 | 3077 | 0.020 |
Why?
|
Lung | 1 | 2024 | 9990 | 0.020 |
Why?
|
Databases, Factual | 1 | 2020 | 7805 | 0.020 |
Why?
|
Phenotype | 1 | 2021 | 16484 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2019 | 15164 | 0.010 |
Why?
|
Models, Biological | 1 | 2019 | 9569 | 0.010 |
Why?
|
Adolescent | 2 | 2021 | 86713 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2020 | 20026 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2019 | 21904 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2019 | 39223 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2021 | 58361 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2020 | 64017 | 0.010 |
Why?
|
Child | 1 | 2021 | 78594 | 0.010 |
Why?
|